Invesco Dynamic Biotechnology & Genome ETF

(AMEX: PBE)
Add to Portfolio
-0.35 (-0.63%)
as of Dec 13, 2019

Profile
Name Invesco Dynamic Biotechnology & Genome ETF
Ticker Symbol PBE
Exchange AMEX
Fund Family Invesco
Description The Invesco Dynamic Biotechnology and Genome ETF is based on the Dynamic Biotech and Genome Intellidex Index. The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances in biotechnology and genetic engineering and research. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.
Sectors Biotech
Underlying Index Dynamic Biotechnology & Genome Intellidex Index
Asset Class Equity
Inception Date 06/23/05
First Trade Date 06/23/05
Leverage Long

Investment Information
Alpha -5.90 Latest Dividend 0.00
Beta 1.43 Dividend Date 09/24/18
Standard Deviation 2.45 Annual Dividend $0.00
Shares Outstanding, $K 4,250.00 Annual Dividend Yield 0.00
Managed Assets, $K 233,155.00 Latest Split N/A
Net Asset Value 54.86 Split Date N/A
First Trade Price 14.89 YTD Return 17.78%
P/E Ratio 38.97 1 Year Return 11.98%
Management Fee 0.57 3 Year Return 35.35%
Options Yes 5 Year Return 6.45%
Gross Expense Ratio 0.57% Net Expense Ratio 0.57%